Link Between Inflammatory Burden Index and One-Year MACE in HFpEF Patients

Overview

This study investigates the association between the Inflammatory Burden Index (IBI) and one-year major adverse cardiovascular events (MACE) in patients with heart failure with preserved ejection fraction (HFpEF) following myocardial infarction (MI). Higher logIBI was found to be independently associated with increased MACE risk, suggesting its potential utility in clinical risk stratification.

Background

Heart failure with preserved ejection fraction (HFpEF) is prevalent among patients with coronary artery disease, particularly those with a history of myocardial infarction (MI). Inflammation plays a critical role in adverse cardiovascular outcomes post-MI, yet its prognostic value in HFpEF remains unclear. Understanding the inflammatory burden can help identify high-risk patients and improve management strategies.

Data Highlights

Key Findings

• Higher logIBI is independently associated with 1-year MACE in HFpEF patients post-MI.
• LogIBI improves risk discrimination when added to a base clinical model.
• The Youden-derived IBI cutoff of 7.70 was used for descriptive grouping and sensitivity analysis.
• Decision curve analysis indicated a higher net benefit after incorporating logIBI.
• Inflammation plays a significant role in adverse remodeling and recurrent cardiovascular events after MI.

Clinical Implications

The Inflammatory Burden Index (IBI) may serve as a practical tool for assessing residual inflammatory burden in HFpEF patients following MI. Clinicians should consider incorporating IBI into risk stratification strategies to identify patients at higher risk for adverse cardiovascular events.

Conclusion

The study highlights the prognostic value of the Inflammatory Burden Index in predicting one-year MACE in HFpEF patients after MI. Further validation is necessary before routine clinical application.

Related Resources & Content

1. Clinical Research in Cardiology, 2024 -- Impact of Previous Myocardial Infarction on Prognosis in Ischaemic HFrEF Patients: Findings from the EVITA-HF Registry
2. Frontiers in Cardiovascular Medicine, 2026 -- Development and validation of a prediction model for 1-year all-cause rehospitalisation after discharge in patients with heart failure with preserved ejection fraction based on the systemic immune-inflammation index
3. Clinical Research in Cardiology, 2024 -- Utilizing the Echocardiographic Killip Score to Forecast Hospital Readmissions and Mortality in Heart Failure Patients
4. Clinical Research in Cardiology — Relationship Between Pulmonary Vein Isolation and Significant Cardiovascular Outcomes in Atrial Fibrillation Patients
5. Inflammatory burden index as a predictor of mortality in septic patients: a retrospective study using the MIMIC-IV database
6. Heart Failure with Preserved Ejection Fraction | New England Journal of Medicine
7. Colchicine in Acute Myocardial Infarction | New England Journal of Medicine